[1]
|
Socała, K., Doboszewska, U., Szopa, A., Serefko, A., Włodarczyk, M., Zielińska, A., Poleszak, E., Fichna, J. and Wlaź, P. (2021) The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders. Pharmacological Research, 172, Article ID: 105840. https://doi.org/10.1016/j.phrs.2021.105840
|
[2]
|
Liu, X., Zhao, Z., Ji, R., Zhu, J., Sui, Q.-Q., Knight, G.E., Burnstock, G., He, C., Yuan, H. and Xiang, Z. (2017) Inhibition of P2X7 Receptors Im-proves Outcomes after Traumatic Brain Injury in Rats. Purinergic Signalling, 13, 529-544.
https://doi.org/10.1007/s11302-017-9579-y
|
[3]
|
Li, H., Sun, J., Du, J., Wang, F., Fang, R., Yu, C., Xiong, J., Chen, W., Lu, Z. and Liu, J. (2018) Clostridium butyricum Exerts a Neuroprotective Effect in a Mouse Model of Traumatic Brain Injury via the Gut-Brain Axis. Neurogastroenterology & Motility, 30, e13260. https://doi.org/10.1111/nmo.13260
|
[4]
|
Zhao, Y.F., Wei, D.N. and Tang, Y. (2021) Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences. Current Neuropharmacology, 19, 1354-1366.
https://doi.org/10.2174/1570159X19666210215123239
|
[5]
|
Ma, Y., Liu, T., Fu, J., Fu, S., Hu, C., Sun, B., Fan, X. and Zhu, J. (2019) Lactobacillus acidophilus Exerts Neuroprotective Effects in Mice with Traumatic Brain Injury. The Journal of Nutrition, 149, 1543-1552.
https://doi.org/10.1093/jn/nxz105
|
[6]
|
Ma, E.L., Smith, A.D., Desai, N., Cheung, L., Hanscom, M., Stoica, B.A., Loane, D.J., Shea-Donohue, T. and Faden, A.I. (2017) Bidirectional Brain-Gut Interactions and Chronic Pathological Changes after Traumatic Brain Injury in Mice. Brain, Behavior, and Immunity, 66, 56-69. https://doi.org/10.1016/j.bbi.2017.06.018
|
[7]
|
Mossad, O. and Erny, D. (2020) The Microbiota-Microglia Axis in Central Nervous System Disorders. Brain Pathology, 30, 1159-1177. https://doi.org/10.1111/bpa.12908
|
[8]
|
Karve, I.P., Taylor, J.M. and Crack, P.J. (2016) The Contribution of Astrocytes and Microglia to Traumatic Brain Injury. British Journal of Pharmacology, 173, 692-702. https://doi.org/10.1111/bph.13125
|
[9]
|
Pluta, R., Januszewski, S. and Czuczwar, S.J. (2021) The Role of Gut Microbiota in an Ischemic Stroke. International Journal of Molecular Sciences, 22, Article No. 915. https://doi.org/10.3390/ijms22020915
|
[10]
|
Benakis, C., Brea, D., Caballero, S., Faraco, G., Moore, J., Murphy, M., Sita, G., Racchumi, G., Ling, L., Pamer, E.G., Iadecola, C. and Anrather, J. (2016) Commensal Microbiota Affects Ischemic Stroke Outcome by Regulating Intestinal γδ T Cells. Nature Medicine, 22, 516-523. https://doi.org/10.1038/nm.4068
|
[11]
|
Dong, X., Zhang, X., Li, C., Chen, J., Xia, S., Bao, X., Ge, J., Cao, X. and Xu, Y. (2022) γδ T Cells Aggravate Blood-Brain-Barrier Injury via IL-17A in Experimental Ischemic Stroke. Neurosci-ence Letters, 776, Article ID: 136563.
https://doi.org/10.1016/j.neulet.2022.136563
|
[12]
|
Haghikia, A., Li, X.S., Liman, T.G., Bledau, N., Schmidt, D., Zimmermann, F., Kränkel, N., Widera, C., Sonnenschein, K., Haghikia, A., Weissenborn, K., Fraccarollo, D., Heimesaat, M.M., Bauersachs, J., Wang, Z., Zhu, W., Bavendiek, U., Hazen, S.L., Endres, M. and Landmesser, U. (2018) Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients with Stroke and Is Related to Proinflammatory Monocytes. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, 2225-2235. https://doi.org/10.1161/ATVBAHA.118.311023
|
[13]
|
Cheng, X., Qiu, X., Liu, Y., Yuan, C. and Yang, X. (2019) Trimethylamine N-Oxide Promotes Tissue Factor Expression and Activity in Vascular Endothelial Cells: A New Link Between Trimethylamine N-Oxide and Atherosclerotic Thrombosis. Thrombosis Research, 177, 110-116. https://doi.org/10.1016/j.thromres.2019.02.028
|
[14]
|
Peh, A., O’Donnell, J.A., Broughton, B.R.S. and Marques, F.Z. (2022) Gut Microbiota and Their Metabolites in Stroke: A Double-Edged Sword. Stroke, 53, 1788-1801. https://doi.org/10.1161/STROKEAHA.121.036800
|
[15]
|
Singh, V., Sadler, R., Heindl, S., Llovera, G., Roth, S., Benakis, C. and Liesz, A. (2018) TThe Gut Microbiome Primes a Cerebroprotective Immune Response after Stroke. Journal of Cerebral Blood Flow & Metabolism, 38, 1293-1298.
https://doi.org/10.1177/0271678X18780130
|
[16]
|
Spychala, M.S., Venna, V.R., Jandzinski, M., Doran, S.J., Durgan, D.J., Ganesh, B.P., Ajami, N.J., Putluri, N., Graf, J., Bryan, R.M. and McCullough, L.D. (2018) Age-Related Changes in the Gut Microbiota Influence Systemic Inflammation and Stroke Outcome. Annals of Neurology, 84, 23-36. https://doi.org/10.1002/ana.25250
|
[17]
|
Zaragoza-Ojeda, M., Apatiga-Vega, E. and Arenas-Huertero, F. (2021) Role of Aryl Hydrocarbon Receptor in Central Nervous System Tumors: Biological and Therapeutic Implications (Re-view). Oncology Letters, 21, Article No. 460.
https://doi.org/10.3892/ol.2021.12721
|
[18]
|
Gutiérrez-Vázquez, C. and Quintana, F.J. (2018) Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity, 48, 19-33. https://doi.org/10.1016/j.immuni.2017.12.012
|
[19]
|
Takenaka, M.C., Gabriely, G., Rothhammer, V., Mascanfroni, I.D., Wheeler, M.A., Chao, C.C., Gutiérrez-Vázquez, C., Kenison, J., Tjon, E.C., Barroso, A., Vandeventer, T., de Lima, K.A., Rothweiler, S., Mayo, L., Ghannam, S., Zandee, S., Healy, L., Sherr, D., Farez, M.F., Prat, A., et al. (2019) Control of Tumor-Associated Macrophages and T Cells in Glioblastoma via AHR and CD39. Nature Neuroscience, 22, 729-740. https://doi.org/10.1038/s41593-019-0370-y
|
[20]
|
Mazzone, A., Gibbons, S.J., Eisenman, S.T., Strege, P.R., Zheng, T., D’Amato, M., Ordog, T., Fernandez-Zapico, M.E. and Farrugia, G. (2019) Direct Repression of Anoctamin 1 (ANO1) Gene Transcription by Gli Proteins. The FASEB Journal, 33, 6632-6642. https://doi.org/10.1096/fj.201802373R
|
[21]
|
Kim, H.-J., Kim, J.-Y., Jung, C.-W., Lee, Y.-S., An, J.-Y., Kim, E.H., Kim, K.-H., Lee, S.P., Park, J.-Y. and Park, M.-J. (2021) ANO1 Regulates the Maintenance of Stemness in Glioblastoma Stem Cells by Stabilizing EGFRvIII. Oncogene, 40, 1490-1502. https://doi.org/10.1038/s41388-020-01612-5
|
[22]
|
Zhuang, Z.-Q., Shen, L.-L., Li, W.-W., Fu, X., Zeng, F., Gui, L., Lü, Y., Cai, M., Zhu, C., Tan, Y.-L., Zheng, P., Li, H.-Y., Zhu, J., Zhou, H.-D., Bu, X.-L. and Wang, Y.-J. (2018) Gut Microbiota Is Altered in Patients with Alzheimer’s Disease. Journal of Alzheimer’s Disease, 63, 1337-1346. https://doi.org/10.3233/JAD-180176
|
[23]
|
Macfarlane, G.T. and Macfarlane, S. (2012) Bacteria, Colonic Fermen-tation, and Gastrointestinal Health. Journal of AOAC International, 95, 50-60. https://doi.org/10.5740/jaoacint.SGE_Macfarlane
|
[24]
|
Vijay, N. and Morris, M.E. (2014) Role of Monocarboxylate Transporters in Drug Delivery to the Brain. Current Pharmaceutical Design, 20, 1487-1498. https://doi.org/10.2174/13816128113199990462
|
[25]
|
Govindarajan, N., Agis-Balboa, R.C., Walter, J., Sananbenesi, F. and Fischer, A. (2011) Sodium Butyrate Improves Memory Function in an Alzheimer’s Disease Mouse Model When Administered at an Advanced Stage of Disease Progression. Journal of Alzheimer’s Disease, 26, 187-197. https://doi.org/10.3233/JAD-2011-110080
|
[26]
|
Bourassa, M.W., Alim, I., Bultman, S.J. and Ratan, R.R. (2016) Butyrate, Neuroepigenetics and the Gut Microbiome: Can a High Fiber Diet Improve Brain Health? Neuroscience Letters, 625, 56-63.
https://doi.org/10.1016/j.neulet.2016.02.009
|
[27]
|
Erny, D., Hrabě de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., Schwierzeck, V., Utermöhlen, O., Chun, E., Garrett, W.S., McCoy, K.D., Diefenbach, A., Staeheli, P., Stecher, B., Amit, I. and Prinz, M. (2015) Host Microbiota Constantly Control Maturation and Function of Microglia in the CNS. Nature Neuroscience, 18, 965-977. https://doi.org/10.1038/nn.4030
|
[28]
|
Doens, D. and Fernández, P.L. (2014) Microglia Receptors and Their Im-plications in the Response to Amyloid β for Alzheimer’s Disease Pathogenesis. Journal of Neuroinflammation, 11, Ar-ticle No. 48.
https://doi.org/10.1186/1742-2094-11-48
|
[29]
|
Cryan, J.F. and Slattery, D.A. (2007) Animal Models of Mood Disorders: Recent Developments. Current Opinion in Psychiatry, 20, 1-7. https://doi.org/10.1097/YCO.0b013e3280117733
|
[30]
|
陶伟伟, 董宇, 刘立, 肖东, 吴浩然, 吴颢昕, 陈刚, 狄留庆, 王汉卿. 基于“脑-肠”轴的肠道菌群影响抑郁症研究进展[J]. 南京中医药大学学报, 2019, 35(2): 234-240. https://doi.org/10.14148/j.issn.1672-0482.2019.0234
|
[31]
|
Ait-Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., Houdeau, E., Theodorou, V. and Tompkins, T. (2014) Probiotic Gut Effect Prevents the Chronic Psychological Stress-Induced Brain Activity Abnormality in Mice. Neurogastroenterology & Motility, 26, 510-520. https://doi.org/10.1111/nmo.12295
|
[32]
|
Wallace, C.J.K., Foster, J.A., Soares, C.N. and Milev, R.V. (2020) The Effects of Probiotics on Symptoms of Depression: Protocol for a Double-Blind Randomized Place-bo-Controlled Trial. Neuropsychobiology, 79, 108-116.
https://doi.org/10.1159/000496406
|